Skip to content
← Full study record

NCT05194735 · MORE INFO

Limitations, agreements, and source contact

Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors · Source last updated 2025-11-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
other Details
Per the clinical trial agreement, the PI may not publish results until after a multi-center publication or a defined period post-study. The sponsor reviews any proposed publication and may delay it to protect proprietary information or file IP. Sponsor controls timing and content of multi-center publications.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
jholland@alaunos.com
organization
Alaunos Therapeutics, Inc.
phone
6502732627
title
Jaymes Holland
Complete source fields
certain Agreement
other Details
Per the clinical trial agreement, the PI may not publish results until after a multi-center publication or a defined period post-study. The sponsor reviews any proposed publication and may delay it to protect proprietary information or file IP. Sponsor controls timing and content of multi-center publications.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
jholland@alaunos.com
organization
Alaunos Therapeutics, Inc.
phone
6502732627
title
Jaymes Holland

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice